Improving therapeutic efficacy of a complement receptor by structure-based affinity maturation.
about
Direct expression and validation of phage-selected peptide variants in mammalian cells.Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy.A high-throughput pipeline for the production of synthetic antibodies for analysis of ribonucleoprotein complexes.
P2860
Improving therapeutic efficacy of a complement receptor by structure-based affinity maturation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Improving therapeutic efficacy ...... ure-based affinity maturation.
@ast
Improving therapeutic efficacy ...... ure-based affinity maturation.
@en
Improving therapeutic efficacy ...... ure-based affinity maturation.
@nl
type
label
Improving therapeutic efficacy ...... ure-based affinity maturation.
@ast
Improving therapeutic efficacy ...... ure-based affinity maturation.
@en
Improving therapeutic efficacy ...... ure-based affinity maturation.
@nl
prefLabel
Improving therapeutic efficacy ...... ure-based affinity maturation.
@ast
Improving therapeutic efficacy ...... ure-based affinity maturation.
@en
Improving therapeutic efficacy ...... ure-based affinity maturation.
@nl
P2093
P2860
P356
P1476
Improving therapeutic efficacy ...... ure-based affinity maturation.
@en
P2093
Hongkang Xi
Jason Chinn
Laura Deforge
Lauri Diehl
Lizette Sturgeon
Menno van Lookeren Campagne
Robert F Kelley
Sachdev S Sidhu
Wyne P Lee
P2860
P304
35605-35611
P356
10.1074/JBC.M109.035170
P407
P577
2009-12-01T00:00:00Z